Converting tumors into vaccine manufacturing factories: DC recruitment, activation and clinical responses with a flt3L-primed in situ vaccine for low-grade lymphoma [nct01976585]. (Q50192032)
Jump to navigation
Jump to search
scientific article published on 6 November 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Converting tumors into vaccine manufacturing factories: DC recruitment, activation and clinical responses with a flt3L-primed in situ vaccine for low-grade lymphoma [nct01976585]. |
scientific article published on 6 November 2014 |
Statements
1 reference
Converting tumors into vaccine manufacturing factories: DC recruitment, activation and clinical responses with a flt3L-primed in situ vaccine for low-grade lymphoma [nct01976585]. (English)
1 reference
Miriam Merad
1 reference
Nina Bhardwaj
1 reference
Seunghee Kim-Schulze
1 reference
Beth Crowley
1 reference
Thomas Davis
1 reference
Tibor Keler
1 reference
Andres Salazar
1 reference
Joshua Brody
1 reference
6 November 2014
1 reference
2
1 reference
Suppl 3
1 reference
P45-P45
1 reference